MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Tardive dystonia manifesting in lid-opening apraxia, oromandibular dystonia, and laterocollis after long-term sulpiride use

    S. Brillman, T. Gongalore (Palo Alto, USA)

  • Targeted sequencing of regulatory regions shows potential SNVs affecting FXN gene expression in Friedreich’s ataxia patients

    V. Swarup, H. Singh, V. Kumar, D. Gupta, A. Ahuja, I. Singh, R. Rajan, A. Srivastava (New Delhi, India)

  • Targeting autophagy to identify novel modulators of Parkinson’s disease using midbrain organoids

    J. Jarazo, I. Rosety, C. Serra-Almeida, R. Marques, C. Saraiva, R. Davis, J. Schwamborn (Esch-sur-Alzette, Luxembourg)

  • Tau PET imaging in a patient with progressive supranuclear palsy-parkinsonism-a case report

    S. Su, Y. Weng, K. Lin, I. Hsiao, K. Huang, C. Lu (Taoyuan City, Taiwan)

  • Technological Approach to Phenotypical Characterization of Functional Movement Disorders

    A. Torquati, G. Fidenzi, LG. Santilio, AE. Elia, N. Golfré Andreasi, G. Devigili, R. Cilia, F. Cosignani, BNG. Conti, P. Amami, S. Piacentini, S. Prioni, R. Eleopra, LM. Romito (Limbiate, Italy)

  • Technological visuo-cognitive training in Parkinson’s disease: Preliminary findings from a pilot randomised controlled trial

    J. Das, G. Barry, R. Vitorio, R. Walker, C. Mcdonald, R. Morris, S. Stuart (Newcastle upom Tyne, United Kingdom)

  • Telehealth Follow-up for Cervical Dystonia Treated with Neurotoxin Injection

    K. Harper, S. Sharp, N. Jones, M. Turchan, M. Hacker, J. Meystedt, S. Ploucher, L. Schattinger, D. Makini, A. Terala, D. Charles (Nashville, USA)

  • Telemedicine and in-person encounters in a Huntington’s disease cohort: virtually the same

    E. Girouard, JF. Daneault, A. James-Palmer, S. Chouinard, A. Richard (Montréal, Canada)

  • Telemedicine challenges in the management of patients with Parkinson’s disease in Central Asia.

    A. Iliazova, E. Zhunusova, C. Shambetova (Bishkek, Kyrgyzstan)

  • Teleprogramming Reduces the Time Needed to Optimize DBS Therapy: Results from the ROAM-DBS study

    A. Gharabaghi, D. Weiss, S. Groppa, L. Lopez Manzanares, A. Schnitzler, R. Alvarez, L. Muñoz-Delgado, C. Luca, J. Karl, V. Marshall, L. Zhang, M. Soileau, B. Dalm, M. Feldman, S. Zauber, H. Lei, L. Luo, B. Walter, C. Wu (Tübingen, Germany)

  • « Previous Page
  • 1
  • …
  • 159
  • 160
  • 161
  • 162
  • 163
  • …
  • 186
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley